This is a Validated Antibody Database (VAD) review about mouse Tnfsf4, based on 13 published articles (read how Labome selects the articles), using Tnfsf4 antibody in all methods. It is aimed to help Labome visitors find the most suited Tnfsf4 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Tnfsf4 synonym: Ath-1; Ath1; CD134L; OX-40L; Ox40l; TXGP1; Tnlg2b; Txgp1l; gp34

BioLegend
rat monoclonal (RM134L)
  • flow cytometry; mouse; 1:200; loading ...
BioLegend Tnfsf4 antibody (BioLegend, RM134L) was used in flow cytometry on mouse samples at 1:200. J Immunother Cancer (2021) ncbi
rat monoclonal (RM134L)
  • flow cytometry; mouse; loading ...
BioLegend Tnfsf4 antibody (Biolegend, 108813) was used in flow cytometry on mouse samples . Cell (2021) ncbi
rat monoclonal (RM134L)
  • flow cytometry; mouse; loading ...; fig s15d
BioLegend Tnfsf4 antibody (Biolegend, RM134L) was used in flow cytometry on mouse samples (fig s15d). Science (2019) ncbi
rat monoclonal (RM134L)
  • blocking or activating experiments; mouse; 10 ug/ml; loading ...; fig 5b
BioLegend Tnfsf4 antibody (Biolegend, RM134L) was used in blocking or activating experiments on mouse samples at 10 ug/ml (fig 5b). Proc Natl Acad Sci U S A (2018) ncbi
Invitrogen
rat monoclonal (RM134L)
  • flow cytometry; mouse; loading ...; fig 2f
Invitrogen Tnfsf4 antibody (eBioscience, 12-5905-81) was used in flow cytometry on mouse samples (fig 2f). Sci Rep (2019) ncbi
rat monoclonal (RM134L)
  • flow cytometry; mouse; loading ...; fig e5c
Invitrogen Tnfsf4 antibody (eBiosciences, RM134L) was used in flow cytometry on mouse samples (fig e5c). Nature (2018) ncbi
rat monoclonal (RM134L)
  • flow cytometry; mouse; loading ...; fig 1c
In order to study the role of PU.1 in the expression of OX40L in dendritic cells, Invitrogen Tnfsf4 antibody (eBioscience, RM134L) was used in flow cytometry on mouse samples (fig 1c). Sci Rep (2016) ncbi
rat monoclonal (RM134L)
  • flow cytometry; mouse
Invitrogen Tnfsf4 antibody (eBioscience, 12-5905-82) was used in flow cytometry on mouse samples . Nat Commun (2016) ncbi
rat monoclonal (RM134L)
  • flow cytometry; mouse; tbl s1
In order to study the role of ICOS in group 2 innate lymphoid cell responses, Invitrogen Tnfsf4 antibody (eBiosciences, RM134L) was used in flow cytometry on mouse samples (tbl s1). Biochem Biophys Res Commun (2015) ncbi
rat monoclonal (RM134L)
  • flow cytometry; mouse; fig 2
Invitrogen Tnfsf4 antibody (eBioscience, RM134L) was used in flow cytometry on mouse samples (fig 2). Mol Immunol (2015) ncbi
Bio X Cell
rat monoclonal (TKS-1)
  • blocking or activating experiments; mouse; fig 5h
Bio X Cell Tnfsf4 antibody (InVivoMab, TKS-1) was used in blocking or activating experiments on mouse samples (fig 5h). Nat Commun (2021) ncbi
rat monoclonal (RM134L)
  • blocking or activating experiments; mouse; loading ...; fig 7a
Bio X Cell Tnfsf4 antibody (Bio X Cell, RM134L) was used in blocking or activating experiments on mouse samples (fig 7a). elife (2015) ncbi
rat monoclonal (TKS-1)
  • blocking or activating experiments; mouse; loading ...; fig 7a
Bio X Cell Tnfsf4 antibody (Bio X Cell, TKS-1) was used in blocking or activating experiments on mouse samples (fig 7a). elife (2015) ncbi
rat monoclonal (RM134L)
  • blocking or activating experiments; mouse; fig 6
Bio X Cell Tnfsf4 antibody (Bio X Cell, RM 134L) was used in blocking or activating experiments on mouse samples (fig 6). J Immunol (2015) ncbi
Miltenyi Biotec
human monoclonal (REA960)
  • flow cytometry; mouse; 1:100; loading ...; fig 5g
Miltenyi Biotec Tnfsf4 antibody (Miltenyi Biotec, 130-116-073) was used in flow cytometry on mouse samples at 1:100 (fig 5g). Nat Commun (2021) ncbi
Santa Cruz Biotechnology
rat monoclonal (OX89)
  • flow cytometry; mouse; fig 2
Santa Cruz Biotechnology Tnfsf4 antibody (Santa Cruz, OX89) was used in flow cytometry on mouse samples (fig 2). Mol Immunol (2015) ncbi
Articles Reviewed
  1. Liu H, Pedros C, Kong K, Canonigo Balancio A, Xue W, Altman A. Leveraging the Treg-intrinsic CTLA4-PKCη signaling pathway for cancer immunotherapy. J Immunother Cancer. 2021;9: pubmed publisher
  2. Uyanik B, Goloudina A, Akbarali A, Grigorash B, Petukhov A, Singhal S, et al. Inhibition of the DNA damage response phosphatase PPM1D reprograms neutrophils to enhance anti-tumor immune responses. Nat Commun. 2021;12:3622 pubmed publisher
  3. Gangoso E, Southgate B, Bradley L, Rus S, Gálvez Cancino F, McGivern N, et al. Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion. Cell. 2021;184:2454-2470.e26 pubmed publisher
  4. Sugiura D, Maruhashi T, Okazaki I, Shimizu K, Maeda T, Takemoto T, et al. Restriction of PD-1 function by cis-PD-L1/CD80 interactions is required for optimal T cell responses. Science. 2019;364:558-566 pubmed publisher
  5. Knox T, Sahakian E, Banik D, Hadley M, Palmer E, Noonepalle S, et al. Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells. Sci Rep. 2019;9:6136 pubmed publisher
  6. Du X, Wen J, Wang Y, Karmaus P, Khatamian A, Tan H, et al. Hippo/Mst signalling couples metabolic state and immune function of CD8α+ dendritic cells. Nature. 2018;558:141-145 pubmed publisher
  7. Choi I, Wang Z, Ke Q, Hong M, Qian Y, Zhao X, et al. Signaling by the Epstein-Barr virus LMP1 protein induces potent cytotoxic CD4+ and CD8+ T cell responses. Proc Natl Acad Sci U S A. 2018;115:E686-E695 pubmed publisher
  8. Yashiro T, Hara M, Ogawa H, Okumura K, Nishiyama C. Critical Role of Transcription Factor PU.1 in the Function of the OX40L/TNFSF4 Promoter in Dendritic Cells. Sci Rep. 2016;6:34825 pubmed publisher
  9. Zhao Y, Chu X, Chen J, Wang Y, Gao S, Jiang Y, et al. Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells. Nat Commun. 2016;7:12368 pubmed publisher
  10. Welten S, Redeker A, Franken K, Oduro J, Ossendorp F, Čičin Šain L, et al. The viral context instructs the redundancy of costimulatory pathways in driving CD8(+) T cell expansion. elife. 2015;4: pubmed publisher
  11. Kamachi F, Isshiki T, Harada N, Akiba H, Miyake S. ICOS promotes group 2 innate lymphoid cell activation in lungs. Biochem Biophys Res Commun. 2015;463:739-45 pubmed publisher
  12. Baeyens A, Saadoun D, Billiard F, Rouers A, Grégoire S, Zaragoza B, et al. Effector T cells boost regulatory T cell expansion by IL-2, TNF, OX40, and plasmacytoid dendritic cells depending on the immune context. J Immunol. 2015;194:999-1010 pubmed publisher
  13. Arduin E, Arora S, Bamert P, Kuiper T, Popp S, Geisse S, et al. Highly reduced binding to high and low affinity mouse Fc gamma receptors by L234A/L235A and N297A Fc mutations engineered into mouse IgG2a. Mol Immunol. 2015;63:456-63 pubmed publisher